patent foramen ovale (PFO) occlusion device (Amplatzer)

From Aaushi
Jump to navigation Jump to search

Indications

* incidence of recurrent cryptogenic stroke in patients with patent foramen ovale is low but 50% lower with Amplatzer[1]

Adverse effects

More general terms

References

  1. 1.0 1.1 1.2 1.3 FDA News Release. October 28, 2016 FDA approves new device for prevention of recurrent strokes in certain patients. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm527096.htm